M Umemoto

410 total citations
8 papers, 354 citations indexed

About

M Umemoto is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Umemoto has authored 8 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Umemoto's work include Cancer, Lipids, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). M Umemoto is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). M Umemoto collaborates with scholars based in Japan, Kuwait and United Kingdom. M Umemoto's co-authors include Yoshihito Yokoyama, Shigemi Sato, Tomomi Sakamoto, Masayuki Futagami, Fahd Al‐Mulla, Shigeki Tsuchida, Yoshiharu Saito, H. Mizunuma, D. Stephen Charnock‐Jones and Makoto Emoto and has published in prestigious journals such as British Journal of Cancer, Molecular Cancer Therapeutics and Gynecologic Oncology.

In The Last Decade

M Umemoto

7 papers receiving 345 citations

Peers

M Umemoto

MB

ONCOL

CR

RM

OG

Laurent Bermont France

Timothy P. Gilliam United States

Jean‐Marc Rey France

Mingbo Cai China

Marina Riggio Argentina

Donatella Amendola Italy

Ilaria Gregnanin Italy

Georgia Liles United States

F. Germán Rodríguez-González Spain

M.S. Henkelman Netherlands

Laurent Bermont France

M Umemoto

207 ×0.8

MB

78 ×0.6

ONCOL

54 ×0.5

CR

33 ×0.6

RM

15 ×0.4

OG

Citations per year, relative to M Umemoto M Umemoto (= 1×) peers Laurent Bermont

Countries citing papers authored by M Umemoto

Since Specialization

Citations

This map shows the geographic impact of M Umemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Umemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Umemoto more than expected).

Fields of papers citing papers by M Umemoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Umemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Umemoto. The network helps show where M Umemoto may publish in the future.

Co-authorship network of co-authors of M Umemoto

This figure shows the co-authorship network connecting the top 25 collaborators of M Umemoto. A scholar is included among the top collaborators of M Umemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Umemoto. M Umemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Abe, Daisuke, et al.. (2025). Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Cancer Diagnosis & Prognosis. 5(5). 597–605.

2.

Yokoyama, Yoshihito, Tatsuhiko Shigeto, M Umemoto, et al.. (2007). Clofibric acid, a peroxisome proliferator–activated receptor α ligand, inhibits growth of human ovarian cancer. Molecular Cancer Therapeutics. 6(4). 1379–1386. 76 indexed citations

3.

Sakamoto, Akiko, Yoshihito Yokoyama, M Umemoto, et al.. (2004). Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours. British Journal of Cancer. 91(4). 633–638. 35 indexed citations

4.

Yokoyama, Yoshihito, D. Stephen Charnock‐Jones, D Licence, et al.. (2003). Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. British Journal of Cancer. 88(2). 237–244. 129 indexed citations

5.

Yokoyama, Yoshihito, Akiko Sakamoto, M Umemoto, et al.. (2003). A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina.. PubMed. 24(5). 435–7. 1 indexed citations

6.

Umemoto, M, Yoshihito Yokoyama, Shigemi Sato, et al.. (2001). Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. British Journal of Cancer. 85(7). 1032–1036. 54 indexed citations

7.

Umemoto, M, et al.. (2001). Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. British Journal of Cancer. 85(7). 1032–1036. 4 indexed citations

8.

Yokoyama, Yoshihito, Shigemi Sato, Masayuki Futagami, et al.. (2000). Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma. Gynecologic Oncology. 77(3). 413–418. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact